Loading
journalsJournal
Breast cancer
Breast Cancer is the official journal of the Japanese Breast Cancer Society, publishing clinical and translational breast cancer research for surgeons, oncologists and pathologists.
Also called: Breast cancer : the journal of the Japanese Breast Cancer SocietyBreast Cancer (Tokyo)Breast Cancer
Overview
Breast Cancer, subtitled the journal of the Japanese Breast Cancer Society, has been published in Tokyo since 1994, originally by Maruzen and now by Springer, which Crossref lists as the publisher. Its NLM title names it as the journal of the Japanese Breast Cancer Society, and as such it is the society's venue for breast cancer research and clinical practice in Japan and internationally. The NLM record lists it as a Japanese serial that is indexed in MEDLINE; it is not listed in DOAJ.
Publisher
Springer · Japanese Breast Cancer Society
Scope
breast cancer
Founded
1994
ISSN
1340-6868
Similar pages
- JournalJournal of mammary gland biology and neoplasia
Shares Ductal carcinoma in situ (DCIS), PubMed & Europe PMC, HER2-positive breast cancer, Triple-negative breast cancer (TNBC).
- JournalThe breast journal
Shares Ductal carcinoma in situ (DCIS), Male breast cancer, PubMed & Europe PMC, HER2-positive breast cancer.
- JournalJournal of breast imaging
Shares Ductal carcinoma in situ (DCIS), PubMed & Europe PMC, HER2-positive breast cancer, Triple-negative breast cancer (TNBC).
- JournalThe Breast
Shares Ductal carcinoma in situ (DCIS), Male breast cancer, PubMed & Europe PMC, HER2-positive breast cancer.
- JournalClinical breast cancer
Shares Ductal carcinoma in situ (DCIS), Male breast cancer, PubMed & Europe PMC, HER2-positive breast cancer.
- JournalBreast cancer research
Shares Ductal carcinoma in situ (DCIS), Male breast cancer, PubMed & Europe PMC, HER2-positive breast cancer.
- TermBreast implant-associated anaplastic large cell lymphoma
Shares Male breast cancer, HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
- TermHow ER and PR are scored on a breast report (Allred score, H score, and why PR is not a UK core item)
Shares Ductal carcinoma in situ (DCIS), Male breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.